Publication: Biomarkers Have Higher Diagnostic and Prognostic Potential Than Other Tools, page-25

....meant to add that with PEB's SP dropping another 20% yesterday (what? ... another cash raise!!), my focus is now clearly on the ability of management.

Prematurely going to the US market on a shoe string budget is "predictably" proving to be the undoing of PEB. I expect a US Pharma firm will probably take over PEB for a song and then immediately announce KP & CMS are on board.

I wonder if (& sincerely hope!) Maria is learning from this lesson.